Beta Bionics, Inc. BBNX recently secured FDA clearance for its Mint patch pump, marking a key milestone in expanding its ...

By bringing its first patch pump to market, Beta Bionics will be able to compete with industry leader Insulet.

Beta Bionics, Inc. ( BBNX) announced FDA clearance of Mint, its new patch pump featuring a reusable and disposable architecture, while unveiling 3D Intelligence, its next-generation insulin dosing ...

Net sales of $27.6 million, up 57% compared to $17.6 million in the first quarter of 2025. Gross margin of 59.5%, up 864 basis points compared to 50.9% in the first quarter of 2025. New patient starts ...

IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to ...

The company plans to launch the smartphone-controlled insulin pump in early 2027 and has separately submitted its ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...